An observational study in Trigeminal Neuralgia, sponsored by Centre Hospitalier Princesse Grace. Recruiting at 1 site in Monaco. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-19.
Sponsored by Centre Hospitalier Princesse Grace · Observational
This study aims to evaluate the outcome of patient treated by radiosurgery on LINAC with high dose rate for classical trigeminal neuralgia
This retrospective and prospective case-series hospital-based study will be conducted in all patients with trigeminal neuralgia treated by radiosurgery on LINAC at the Centre Hospitalier Princesse Grace from april 2018 to january 2028. Patients will be treated with frameless technic and receive 90 Gy delivered with high dose rate on the intra cisternal portion of the trigeminal nerve.
140 studies on the registry are indexed under Trigeminal Neuralgia; 44 are open to participants now.
This study's planned enrollment of 150 is above the median of 84 across 38 observational studies indexed under Trigeminal Neuralgia.
Browse Trigeminal Neuralgia studies →Centre Hospitalier Princesse Grace is the lead sponsor of 19 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
all patients with trigeminal neuralgia treated by radiosurgery on LINAC
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Pain relief
Barrow Neurological Institute pain intensity scale - score I to V - V is the worst Barrow Neurological Institute (BNI) pain intensity scale Barrow Neurological Institute (BNI) pain intensity scale
Time frame: 24 months
Toxicity of radiosurgery
Common Terminology Criteria for Adverse Events version 5.0 - grade 1 to 5 - 5 is the worst
Time frame: 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years
Variation of quality of life
Short Form 36 Health Survey - score 0 to 100 - 0 is the worst
Time frame: 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years
Started Dec 2021 (actual). Primary completion is estimated for Dec 2026, 60 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Princesse Grace